These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30711333)

  • 1. Glutamine and the Tumor Immune Microenvironment.
    Faiena I; Ueno D; Shuch B
    Eur Urol; 2019 May; 75(5):764-765. PubMed ID: 30711333
    [No Abstract]   [Full Text] [Related]  

  • 2. IL-23 links glutamine addiction and immune function.
    Bradley CA
    Nat Rev Urol; 2018 Dec; 15(12):725. PubMed ID: 30361494
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphoma Microenvironment and Immunotherapy.
    Xu ML; Fedoriw Y
    Surg Pathol Clin; 2016 Mar; 9(1):93-100. PubMed ID: 26940270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pi (Spleen)-deficiency syndrome in tumor microenvironment is the pivotal pathogenesis of colorectal cancer immune escape.
    Sun XG; Lin XC; Diao JX; Yu ZL; Li K
    Chin J Integr Med; 2016 Oct; 22(10):789-94. PubMed ID: 26556710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supraglottic laryngeal tumor microenvironmental factors facilitate STAT3 dependent pro-tumorigenic switch in tumor associated macrophages to render utmost immune evasion.
    Goswami KK; Barik S; Banerjee S; Bhowmick AK; Biswas J; Bose A; Baral R
    Immunol Lett; 2013; 156(1-2):7-17. PubMed ID: 24029664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linking tumor glycolysis and immune evasion in cancer: Emerging concepts and therapeutic opportunities.
    Ganapathy-Kanniappan S
    Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):212-220. PubMed ID: 28400131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Evasion in Tumor's Own Sweet Way.
    Tang H; Fu YX
    Cell Metab; 2018 May; 27(5):945-946. PubMed ID: 29628418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma.
    Eckert AW; Wickenhauser C; Salins PC; Kappler M; Bukur J; Seliger B
    J Transl Med; 2016 Apr; 14():85. PubMed ID: 27044404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new perspective on immune evasion: escaping immune surveillance by inactivating tumor suppressors.
    Mergener S; Peña-Llopis S
    Signal Transduct Target Ther; 2022 Jan; 7(1):15. PubMed ID: 35027544
    [No Abstract]   [Full Text] [Related]  

  • 10. [Development of novel immunotherapy targeting cancer immune evasion].
    Tamada K
    Gan To Kagaku Ryoho; 2014 Sep; 41(9):1062-5. PubMed ID: 25248888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-promoting effect of IL-23 in mammary cancer mediated by infiltration of M2 macrophages and neutrophils in tumor microenvironment.
    Nie W; Yu T; Sang Y; Gao X
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1400-1406. PubMed ID: 27956175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the tumor microenvironment by immunotherapy: part 2.
    Leibovici J; Itzhaki O; Huszar M; Sinai J
    Immunotherapy; 2011 Nov; 3(11):1385-408. PubMed ID: 22053888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolic Competition in Tumor Microenvironment].
    Eikawa S; Udono H
    Gan To Kagaku Ryoho; 2017 Nov; 44(11):972-976. PubMed ID: 29138369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated macrophages and the profile of inflammatory cytokines in oral squamous cell carcinoma.
    Costa NL; Valadares MC; Souza PP; Mendonça EF; Oliveira JC; Silva TA; Batista AC
    Oral Oncol; 2013 Mar; 49(3):216-23. PubMed ID: 23089461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic therapy: a new paradigm for managing malignant brain cancer.
    Seyfried TN; Flores R; Poff AM; D'Agostino DP; Mukherjee P
    Cancer Lett; 2015 Jan; 356(2 Pt A):289-300. PubMed ID: 25069036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of HLA class I-mediated immune evasion of human tumors and their role in resistance to immunotherapies.
    Seliger B
    HLA; 2016 Nov; 88(5):213-220. PubMed ID: 27659281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated macrophages: implications in cancer immunotherapy.
    Petty AJ; Yang Y
    Immunotherapy; 2017 Mar; 9(3):289-302. PubMed ID: 28231720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lewis Lung Cancer Cells Promote SIGNR1(CD209b)-Mediated Macrophages Polarization Induced by IL-4 to Facilitate Immune Evasion.
    Yan X; Li W; Pan L; Fu E; Xie Y; Chen M; Mu D
    J Cell Biochem; 2016 May; 117(5):1158-66. PubMed ID: 26447454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the inflammatory microenvironment in thyroid carcinogenesis.
    Cunha LL; Marcello MA; Ward LS
    Endocr Relat Cancer; 2014 Jun; 21(3):R85-R103. PubMed ID: 24302667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically Engineered Macrophages: A Potential Platform for Cancer Immunotherapy.
    Moyes KW; Lieberman NA; Kreuser SA; Chinn H; Winter C; Deutsch G; Hoglund V; Watson R; Crane CA
    Hum Gene Ther; 2017 Feb; 28(2):200-215. PubMed ID: 27758144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.